Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Not yet recruiting 2Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Breast Neoplasms 161Neoplasms 118Carcinoma, Non-Small-Cell Lung 92Prostatic Neoplasms 86Colorectal Neoplasms 86Lung Neoplasms 77Leukemia, Myeloid, Acute 53Carcinoma, Hepatocellular 53Pancreatic Neoplasms 46Neoplasm Metastasis 44Multiple Myeloma 39Recurrence 36Triple Negative Breast Neoplasms 32Squamous Cell Carcinoma of Head and Neck 29Ovarian Neoplasms 29Brain Neoplasms 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Melanoma 28Glioblastoma 28Uterine Cervical Neoplasms 27Head and Neck Neoplasms 27Stomach Neoplasms 26Rectal Neoplasms 25Small Cell Lung Carcinoma 23Carcinoma, Renal Cell 22Glioma 21Sarcoma 19Lymphoma, B-Cell 19Endometrial Neoplasms 19Lymphoma, Follicular 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Hepatic Insufficiency × 90 days × Clear all
NCT07559474 2026-04-30

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

Incyte Corporation

Phase 1 Not yet recruiting
16 enrolled
Lymphoid

Liver Diseases, Lymphoma, Follicular, Hepatic Insufficiency

NCT07550634 2026-04-24

Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment

MindRank AI Ltd

Phase 1 Not yet recruiting
32 enrolled
Lymphoid

Lymphoma, Follicular, Hepatic Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡